Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: REGENERON PHARMACEUTICALS INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2017-09-21 to 2027-09-24
Current total value of award: $611318728
Description: (1) REVISE PERIOD OF PERFORMANCE, (2) ADD CLIN 0007 COV2-NEXT GEN, STATEMENT OF WORK, (3) OBLIGATED: $326,475,498.00, AND (4) ADD PROHIBITION ON A BYTEDANCE COVERED APPLICATION